Ductal carcinoma in situ of the breast and heparanase-1 expression: A molecular explanation for more aggressive subtypes

Journal of the American College of Surgeons

Volumn 200, Issue 3, 2005, Pages 328-335

  Maxhimer, Justin B ^a   Pesce, Catherine E ^a   Stewart, Robyn A ^a   Gattuso, Paolo ^a   Prinz, Richard A ^a   Xu, Xiulong ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSIDASE; HEPARAN SULFATE; HEPARANASE; PROTEOGLYCAN;

ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; BREAST DUCT; CARCINOMA IN SITU; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 14544296126     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.10.034     Document Type: Article

References (37)

1. A. Adeyinka, E. Emberley, Y. Niu Analysis of gene expression in ductal carcinoma in situ of the breast Clin Cancer Res 8 2002 3788 3795
2. V. Luzzi, V. Holtschlag, M.A. Watson Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays Am J Pathol 158 2001 2005 2010
3. J.D. Wulfkuhle, D.C. Sgroi, H. Krutzsch Proteomics of human breast ductal carcinoma in situ Cancer Res 62 2002 6740 6749
4. E.K. Latta, S. Tjan, R.K. Parkes, F.P. O'Malley The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast Mod Pathol 15 2002 1318 1325
5. M.L. Berthe, M. Esslimani Sahla, P. Roger Mannose-6-phosphate/insulin- like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas Eur J Cancer 39 2003 635 642
6. D.R. Nathanson, G.M. Nash, B. Chen Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique J Am Coll Surg 197 2003 419 425
7. D. Porter, J. Lahti-Domenici, A. Keshaviah Molecular markers in ductal carcinoma in situ of the breast Mol Cancer Res 1 2003 362 375
8. M.J. Silverstein Ductal carcinoma in situ of the breast Annu Rev Med 51 2000 17 32
9. M.J. Silverstein, D.N. Poller, J.R. Waisman Prognostic classification of breast ductal carcinoma-in-situ Lancet 345 1995 1154 1157
10. M.D. Lagios, F.R. Margolin, P.R. Westdahl, M.R. Rose Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence Cancer 63 1989 618 624
11. G.F. Schwartz The role of excision and surveillance alone in subclinical DCIS of the breast Oncology (Huntington) 8 1994 21 26 ; discussion 26-27, 31-35
12. T.L. Adamovich, R.M. Simmons Ductal carcinoma in situ with microinvasion Am J Surg 186 2003 112 116
13. J.H. Wong, K.H. Kopald, D.L. Morton The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer Arch Surg 125 1990 1298 1301 ; discussion 1301-1302
14. K. Dowlatshahi, H.C. Snider Jr, R. Kim Axillary node status in nonpalpable breast cancer Ann Surg Oncol 2 1995 424 428
15. M.J. Silverstein, M.D. Lagios, P.H. Craig A prognostic index for ductal carcinoma in situ of the breast Cancer 77 1996 2267 2274
16. M.J. Silverstein The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast Am J Surg 186 2003 337 343
17. M.B. Fairbanks, A.M. Mildner, J.W. Leone Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer J Biol Chem 274 1999 29587 29590
18. R.V. Iozzo, J.D. San Antonio Heparan sulfate proteoglycans heavy hitters in the angiogenesis arena J Clin Invest 108 2001 349 355
19. R.V. Iozzo Heparan sulfate proteoglycans intricate molecules with intriguing functions J Clin Invest 108 2001 165 167
20. C.R. Parish, C. Freeman, M.D. Hulett Heparanase a key enzyme involved in cell invasion Biochim Biophys Acta 1471 2001 M99 M108
21. I. Vlodavsky, O. Goldshmidt, E. Zcharia Mammalian heparanase involvement in cancer metastasis, angiogenesis and normal development Semin Cancer Biol 12 2002 121 129
22. I. Vlodavsky, Y. Friedmann Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis J Clin Invest 108 2001 341 347
23. M. Bar-Ner, M. Mayer, V. Schirrmacher, I. Vlodavsky Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix J Cell Physiol 128 1986 299 306
24. X. Xu, R.M. Quiros, J.B. Maxhimer Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas a potential role in tumor metastasis Clin Cancer Res 9 2003 5968 5979
25. J.B. Maxhimer, R.M. Quiros, R. Stewart Heparanase-1 expression is associated with the metastatic potential of breast cancer Surgery 132 2002 326 333
26. A. Koliopanos, H. Friess, J. Kleeff Heparanase expression in primary and metastatic pancreatic cancer Cancer Res 61 2001 4655 4659
27. I. Vlodavsky, Y. Friedmann, M. Elkin Mammalian heparanase gene cloning, expression and function in tumor progression and metastasis Nat Med 5 1999 793 802
28. A.W. Kim, X. Xu, E.F. Hollinger Human heparanase-1 gene expression in pancreatic adenocarcinoma J Gastrointest Surg 6 2002 167 172
29. M. Hidalgo, S.G. Eckhardt Development of matrix metalloproteinase inhibitors in cancer therapy J Natl Cancer Inst 93 2001 178 193
30. K. Mimori, H. Ueo, C. Shirasaka, M. Mori Clinical significance of MT1-MMP mRNA expression in breast cancer Oncol Rep 8 2001 401 403
31. M.D. Sternlicht, A. Lochter, C.J. Sympson The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis Cell 98 1999 137 146
32. J. Westermarck, V.M. Kahari Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 1999 781 792
33. T.N. Wight, M.G. Kinsella, E.E. Qwarnstrom The role of proteoglycans in cell adhesion, migration and proliferation Curr Opin Cell Biol 4 1992 793 801
34. G. David Integral membrane heparan sulfate proteoglycans FASEB J 7 1993 1023 1030
35. M. Bernfield, M. Gotte, P.W. Park Functions of cell surface heparan sulfate proteoglycans Annu Rev Biochem 68 1999 729 777
36. E. Zcharia, S. Metzger, T. Chajek-Shaul Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis J Mammary Gland Biol Neoplasia 6 2001 311 322
37. M. Elkin, I. Cohen, E. Zcharia Regulation of heparanase gene expression by estrogen in breast cancer Cancer Res 63 2003 8821 8826